2003.1-CT
2003.1-CT
Training Topics 1
Where to find compliance documents Signs & symptoms of diseases How diseases are spread
Blood to blood Blood/opim to mucous membranes All patient care CPR BVM/Combitube use Active bleeding/bleeding control See SOP ADM01-infection control Draft Medical Waste SOP Workplace controls:
Universal precautions-Assume all patients to be contagious
mask//gown/goggles Gloves Biohazard bags
2003.1-CT
Training Topics 2
Hepatitis B vaccinations Personal Protective Equipment (PPE)
Chose the right PPE for the situation
2003.1-CT
2003.1-CT
no contact
2003.1-CT 2003 Safety Priority Consultants, LLC 8
1 of 3
2 of 3
10
3 of 3
11
Hepatitis
Viruses attack the liver A, B, C, D, E, B is most serious C also highly infectious Transmitted through blood, body fluids, sexual contact
2003.1-CT 2003 Safety Priority Consultants, LLC 12
Hepatitis B
survives 7-10 days outside the body in dried state found mainly in blood, semen, vaginal secretions incubation 6 weeks to 6 months, average 2-3 months 30% have no symptoms
2003.1-CT 2003 Safety Priority Consultants, LLC 14
2003.1-CT
15
1980
2003.1-CT
1985
1990
1995
2000
16
Hepatitis C (HCV)
transmitted mainly through contaminated punctures, human bites, transfusions 40-60% of acute viral hepatitis cases in U.S. incubation 2-26 weeks, average 6-7 weeks 80% have no signs or symptoms
2003.1-CT 2003 Safety Priority Consultants, LLC 17
HIV/AIDS
Human Immunodeficiency Virus
2003.1-CT
21
Progression of AIDS
End stage
Diagnosis
Symptoms
HIV Positive
Exposure
Pre-exposure
2003.1-CT 2003 Safety Priority Consultants, LLC 22
2003.1-CT
cases
23
2003.1-CT
28
2003.1-CT
33
2003.1-CT
34
2003.1-CT
35
2003.1-CT
37
Latex Allergy
local redness, itching runny nose, watery eyes, sneezing or hayfever symptoms difficulty breathing anaphylactic reaction cross allergies to foods
2003.1-CT 2003 Safety Priority Consultants, LLC 38
Barriers to Infections
Administrative Controls Engineering Controls:
Gloves, masks, goggles, etc. Biohazard storage bags and containers
Hepatitis B Vaccinations
free of charge 3 shots over 6 months 85-97% are protected sign waiver if you refuse; change your mind any time titer testing to verify seroconversion
2003.1-CT 2003 Safety Priority Consultants, LLC 40
2003.1-CT
42
Sharps container
2003.1-CT
43
2003.1-CT
44
2003.1-CT
45
2003.1-CT
46
Post-Exposure: Reporting
First Aid first, then notify supervisor Non-significant exposure
clothing, intact skin
Significant
eyes/nose/mouth contaminated puncture non-intact skin human bite
2003.1-CT 2003 Safety Priority Consultants, LLC 47
Post-Exposure: Procedure
report to supervisor, determine significance referral to health care professional (ER) bring paperwork (report of initial exposure) medical evaluation, blood testing notification of all results written opinion to employer document on OSHA 200 log
2003.1-CT 2003 Safety Priority Consultants, LLC 48
Confidentiality
you cannot disclose the source patients infectivity or HIV status
2003.1-CT
49
Comments? Questions?
2003.1-CT
50